135 filings
8-K
GOSS
Gossamer Bio Inc
7 May 24
Gossamer Bio Announces First Quarter 2024 Financial Results and Provides Business Update
4:02pm
10-Q
2024 Q1
GOSS
Gossamer Bio Inc
Quarterly report
7 May 24
4:01pm
8-K
GOSS
Gossamer Bio Inc
6 May 24
Entry into a Material Definitive Agreement
7:31am
ARS
2024 FY
GOSS
Gossamer Bio Inc
26 Apr 24
Annual report to shareholders
2:20pm
DEFA14A
GOSS
Gossamer Bio Inc
24 Apr 24
Additional proxy soliciting materials
4:02pm
8-K
8ktcvztyq gyh52
12 Mar 24
Gossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan
4:01pm
S-8
fioph6pn nx0
5 Mar 24
Registration of securities for employees
7:37am
8-K
k4ivnj 2y8
5 Mar 24
Gossamer Bio Announces Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
7:31am
8-K
eld8x d9lz6vaep6
4 Mar 24
Other Events
4:02pm
8-K
xp2n hqdtv52e8zh
29 Nov 23
Gossamer Bio Announces Appointment of John Quisel, J.D., Ph.D., to its Board of Directors
4:01pm
8-K
q20k6xotyx27om9uu13
27 Nov 23
Departure of Directors or Certain Officers
4:01pm
8-K
pxc7s
9 Nov 23
Gossamer Bio Announces Third Quarter 2023 Financial Results and Provides Business Update
7:31am
8-K
wwc9zy 7oamc67jt25
20 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:01pm
8-K
34krzdi1
7 Sep 23
Departure of Directors or Certain Officers
5:00pm
EFFECT
dcqo9 775ai
29 Aug 23
Notice of effectiveness
12:15am
424B3
rpxg8f gjemy46ci
28 Aug 23
Prospectus supplement
4:29pm
UPLOAD
bkcnfglqn1
24 Aug 23
Letter from SEC
12:00am